articleTop 10% cited

A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients

European Journal of Cancer · 2000 · Vol. 36(14) · pp. 1796–1807

Kristin Bjordal✉(Norwegian Cancer Society)Alexander de Graeff(Utrecht University)Peter Fayers(St Olav's University Hospital)Eva Hammerlid(Sahlgrenska University Hospital)C van Pottelsberghe(European Organisation for Research and Treatment of Cancer)Desmond Curran(European Organisation for Research and Treatment of Cancer)Marianne Ahlner‐Elmqvist(Lund University)E.J. Maher(Mount Vernon Hospital)J Meyza(The Maria Sklodowska-Curie National Research Institute of Oncology)A. Brédart(Institut Jules Bordet)A.-L. Söderholm(Helsinki University Hospital)JI Arrarás(Complejo Hospitalario de Navarra)Jocelyne S. Feine(McGill University)Helmut Abendstein(St Olav's University Hospital)Randall P. Morton(Greenlane Clinical Centre)T. Pignon(Hôpital de la Timone)Huguenin Pu(University Hospital of Zurich)A Bottomly(European Organisation for Research and Treatment of Cancer)S. Kaasa(St Olav's University Hospital)

View via DOI Publisher page

Head and Neck Cancer Studies Oral health in cancer treatment Colorectal and Anal CarcinomasMedicineHead and neck cancerCancerHead and neckReliability (semiconductor)Physical therapySurgeryInternal medicine

MeSH terms

AdultAgedAged, 80 and overCarcinoma, Squamous CellFemaleHead and Neck NeoplasmsHealth Status IndicatorsHumansMaleMiddle AgedQuality of LifeSurveys and QuestionnairesSensitivity and SpecificityTime Factors

Citations

798

FWCI

9.22

field-weighted impact

References

Percentile

98%

vs. same field & year

Citations per year

Cited by

Quality of life research within the EORTC—the EORTC QLQ-C30